About IL-2 toxicity, most patients experienced erythema and induration at the IL-2 injection site and constitutional symptoms, such as fever, chills, fatigue and malaise; these symptoms were present only during the days of IL-2 administration and completely regressed during the days of suspension and at the end of the IL-2 cycles. This evidence concerns the gene IL2 and Erythema.